Morgan KM, Anderson KT, Johnston ME, Dasqupta R, Crowley JJ, Fahy AS, Patricia E Ladd et al. Interhospital variability in localization techniques for small pulmonary nodules in children: A pediatric surgical oncology research collaborative study. Pediatr Surg June 2022 57(6):1013-1017. PMID:35307194
https://www.sciencedirect.com/science/article/pii/S0022346822001397
Stefansson VTN, Nair V, Melsom T, Looker HC, Mariani LH, Eichinger F, Patricia E Ladd et al. Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease. Kidney Int. December 2022 102(6):1345-1358. PMID: 36055599
https://www.sciencedirect.com/science/article/pii/S0085253822006895
Schaub JA, AlAkwaa FM, McCown PJ, Naik AS, Nair V, Eddy S, Menon R, Otto EA, Demeke D, Hartman J, Fermin D, O'Connor CL, Subramanian L, Bitzer M, Harned R, Ladd P, Pyle L, Pennathur S, Inoki K, Hodgin JB, Brosius FC 3rd, Nelson RG, Kretzler M, Bjornstad P. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. J Clin Invest. 2023 Mar 1;133(5). PubMed PMID: 36637914
Robinson EB, Jordan G, Katz D, Sundaram SS, Boster J, Brigham D, Ladd P, Chan CM, Shay RL, Ochmanek E, Annam A. Congenital Portosystemic Shunts: Variable Clinical Presentations Requiring a Tailored Endovascular or Surgical Approach. JPGN Rep. 2023 Feb;4(1):e279. PubMed PMID: 37181921
Sen T, Ju W, Nair V, Ladd P, Menon R, Otto EA, Pyle L, Vigers T, Nelson RG, Arnott C, Neal B, Hansen MK, Kretzler M, Bjornstad P, Heerspink HJL. Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes. Kidney Int. 2023 Oct;104(4):828-839. PubMed PMID: 37543256